Offer - Urjas Oil for just ₹ 1 X
Jotair LA is an allopathic medicine The correct dosage of Jotair LA depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Jotair La is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Jotair La safe for pregnant women?
Jotair LA shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Jotair La safe during breastfeeding?
Jotair LA may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Jotair La on the Kidneys?
Jotair LA rarely harms the kidneys.
What is the effect of Jotair La on the Liver?
Jotair LA can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Jotair La on the Heart?
You may experience side effects on your heart after taking Jotair LA. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Jotair La should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Jotair La unless your doctor advises you to do so -
Is this Jotair La habit forming or addictive?
Jotair La is not addictive in nature.
Interaction between Food and Jotair La
Due to a lack of research, nothing can be said about the consequences of taking Jotair La together with food.
Interaction between Alcohol and Jotair La
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Jotair La.
Yes, Jotair LA causes a headache. It is a common side effect of this drug. However, the exact cause behind this is unknown. If you experience a severe headache after taking this drug, consider taking a mild painkiller, applying balms and complete rest. Even if the pain does not subside then discuss with your doctor immediately.
Yes, Jotair LA can be taken for running nose. It works by blocking a compound (leukotriene) which is responsible for it.
No, Jotair LA does not cause erectile dysfunction. It has not been reported by the patients who are taking this drug. It is not a known side effect of this drug.
Yes, Jotair LA help with bronchitis. Jotair LA block the action of leukotriene which is responsible for narrowing the airways. By blocking the leukotriene Jotair LA prevents the narrowing of airways.
Yes, Jotair LA causes dry mouth because it decreases the saliva secretion in your mouth. It is an uncommon side effect of this drug. If you experience excess dry mouth after taking this drug, keep yourself hydrated with juices, shakes and ample water.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167